Contact
Header_1077x260px_About_Profil.jpg

GLP-1 agonists: an option for NAFLD?

Profil World - The clinical diabetes research newsletter - October 2021

Free Online Seminar: Advancements in oral insulin development

Oral insulin: The future of insulin therapy?

EU Clinical Trials Regulation (EU-CTR) enters application on 31 January 2022

Profil World - The clinical diabetes research newsletter - July 2021

Can Remote Decentralised Clinical Trials enhance clinical research?

Gender ratio in clinical trials – are there less female trial participants?

Free Online Seminar: IMP manufacturing services for clinical trials in EU

Reporting of study results: a challenge?

Profil World - The clinical diabetes research newsletter - March 2021

Profil leads the way in establishing audit trail review procedures in clinical studies using visual data analytics

Free Online Seminar: Audit trail review in clinical studies using visual data analytics

Can serious games motivate teenagers with diabetes to adhere to their treatment?

Running clinical trials at Profil during pandemic times

Profil World - The clinical diabetes research newsletter - December 2020

β3-adrenoceptor agonist Mirabegron – a candidate anti-obesity drug?

Once-weekly basal insulin analogue in clinical development

Glycaemic control in type 1 diabetes – effects of diabetes technology and socioeconomic status

Profil World - The clinical diabetes research newsletter - October 2020

Free Online Seminar: Profil - the leading CRO for metabolic research

Profil starts in-house production of tubing sets for ClampArt®, reinforcing the quality of world-class glucose clamp trials

The rollercoaster life of inhaled insulin

Heart failure: SGLT2 inhibitors moving beyond diabetes

Bringing the real world to clinical research: the use of wearables in pivotal trials

Profil World - The clinical diabetes research newsletter - June 2020

When Artificial Intelligence and Artificial Pancreas meet

Non invasive CGM; hope at the horizon?

Free Online Seminar on insulin biosimilars

Think Tank highlights CROs role the adoption of AI-powered health innovation

Fighting Corona: Profil's contribution

Clinical study shows better clamp quality with Clamp-PID algorithm

A novel method to determine the pharmacodynamic onset of action of prandial insulins

Profil World - The clinical diabetes research newsletter - February 2020

Type 1 Diabetes and mild cognitive impairment

Free Online Seminar on early phase obesity research

Trustworthy AI in healthcare - it's TIME TO DELIVER

Profil wishes merry christmas and a happy new year 2020

Beer or wine or both – and if both, in which order?

Profil World - The clinical diabetes research newsletter - November 2019

Lipohypertrophy – New insights into an old issue?

What news in the treatment of Type 2 diabetes was presented at EASD 2019?

Finally breakthrough in the immunological approach to type 1 diabetes

Current developments in approaches to bridging studies

iPDM Goes Europe: tangible impact on diabetes patients and care

New PID-algorithm for automated glucose clamps

"Profil World" - The clinical diabetes research newsletter - July 2019

Dual-hormone artificial pancreas systems

Dr. Tim Heise about Profil's 2018 Science Report

Is there a ‘true’ insulin time action profile?

Applications of iontophoresis in studies investigating microvasculature

The ideal basal insulin?

"Profil World" - The clinical diabetes research newsletter - May 2019

Profil is co-founder of KomIT

NAFLD/NASH: a ticking bomb not yet defused

Profil joined iPDM-GO

Free Online Seminar on Diagnosis of NAFLD

Are soccer players with dark skin tone more likely to receive red cards?

"Profil World" - The clinical diabetes research newsletter - February 2019

Artificial pancreas in type 2 diabetes

Free Online Seminar titled "Understanding the results of glucose clamp studies"

Digital Diabetes: better trials, better drugs, better care

Glucose-Infusion-Rate based categorization of glucose clamps

Update on Brexit: Impact on future and current clinical trials in Germany

Happy new year 2019

Pramlintide as adjunct therapy for the treatment of type 1 diabetes

New data on cardiovascular outcomes with dapagliflozin

Glucose-Responsive Insulin

New strategies for the treatment of obesity and metabolic dysfunctions

What news in the treatment of Type 2 diabetes was presented at EASD 2018?

Profil at 18th Annual Diabetes Technology Meeting

Artificial Intelligence to Screen for Diabetic Retinopathy; The Times They Are A-Changin‘.

New timelines for the EU Portal and implementation of the EU Clinical Trial Regulation

"Profil World" - The clinical diabetes research newsletter - October 2018

54th EASD Annual Meeting – Profil’s contributions to the scientific sessions

Profil explores opportunities for artificial pancreas in type 2 diabetes

Work stress is the new smoking

Profil at EASD Annual Meeting 2018

Do-It-Yourself Artificial Pancreas systems (DIY APS)

Targeting the incretin/glucagon system: a glimmer of hope

Free Online Seminar on EU-funded R&D partnerships in healthy living and active ageing

Even moderate overweight increases the risk for cardiovascular disease, recent study says

The new European Medical Device Regulation (MDR)

Clamp studies with ultra-long-acting insulins – New challenges for an old procedure

"Profil World" - The clinical diabetes research newsletter - July 2018

Diabetes: A paradigm case for rewarding innovation in value-based healthcare

Gut Microbiota and Type 2 Diabetes

CGM in pregnant women with type 1 diabetes

Cardiovascular endpoints in trials with glucose-lowering medications

Smart ideas for noninvasive glucose monitoring

SUSTAIN 7 - Semaglutide is superior to Dulaglutide

Vitamin D supplementation – is there a role in type 1 diabetes?

Profil announces new live Online Seminar Session

Influence of Technical Downtime on the Outcome of Automated Glucose clamps

D4kids: Profil joined a new pan-European Artificial Pancreas initiative

Profil is committed to the highest quality - including the training of our staff

Cardiovascular outcome trials of incretin drugs: what have we learned?

Nutrition standardization during clinical trials: Methods of standardized food intake

Insulin injection: recent improvements and alternatives

"Profil World" - The clinical diabetes research newsletter - March 2018

Flow-Mediated Vasodilation: why we do it and how to do it

Pancreatic ß-cell function changes in response to pharmacological or life-style interventions

Free Online Seminar on endothelial function in clinical trials using Flow-Mediated Vasodilation

Implementation of EU directive 536/2014: Ethic committees prepare for the next level

Dr. Tim Heise about Profil's 2017 Science Report

Advanced precision of Continuous Whole Blood Glucose concentration measurements

Artificial pancreas for type 2 diabetes: the CLOSE project

Bringing glucose clamps up to speed for novel insulins

Professor Hans de Vries joins Profil

Profil wishes merry christmas and a happy new year

Health claims & the need for scientific evidence in food studies

The need for speed

"Profil World" - The clinical diabetes research newsletter - November 2017

Treatment with SGLT2 inhibitors: is there hope for renal protection?

Can a dual-hormone closed loop delivery systems become a “technical cure” of diabetes?

Biomarkers for vascular integrity in patients with diabetes mellitus (Part 2)

Insulin therapy: Profil presented at EASD 2017

Novelties in the treatment of Type 2 diabetes presented at the EASD 2017

Minimal Blood Loss with Automated Glucose Clamps: A new configuration of ClampArt

Non-invasive liver fat and liver stiffness screening at Profil

Alternate –Day Fasting: Any better than other Diets?

Inhaled insulins - a valid option in the treatment of diabetes?

HbA1c, a diabetes marker for the past and for the future?

Free Online Seminar on digitalization in diabetes by Prof. Lutz Heinemann

One insulin tablet a day… Profil study shows promise for alternative to insulin injections

Biomarkers for vascular integrity in patients with diabetes mellitus

Glucose Clamps: 2 steps towards hepatic and peripheral insulin sensitivity

"Profil World" - The clinical diabetes research newsletter - July 2017

Error Grid Analysis

Update to the EU Directive 536/2014 and Brexit

Looking beyond blood glucose - the islet of Langerhans

Considering the Complexity of Food-Drug Interactions for drug development

Smart Insulin Patches or Glucose-Responsive Insulin Delivery Systems

A different design of Glucose Clamps: Fixed Rate of Blood Glucose Change rather than Fixed Blood Glucose Levels

Targeting LDL cholesterol – How low do we need to get it? And at what price…?

Don't miss ADA 2017 President's Oral Session

Will noninvasive glucose monitoring end in tears?

Meet us at the MedTech Summit 2017

First in Human (FIH) Trials: New draft guideline for Risk Mitigation

New Study about Sugar vs. Calorie-free Sweeteners

InnoDiaCare: Summer School for Digital Innovation in Diabetes Care

"Profil World" - The clinical diabetes research newsletter - April 2017

Profil recent publications on diabetes

How clinical trial results are distorted by reporting bias

Your blood glucose meter might not be sufficiently accurate! (Update 03/2017)

How do SGLT2 inhibitors improve cardiovascular outcomes?

Patient initiated research – How involvement of patients could help improve diabetes research

Glucose clamps: 2 steps towards insulin sensitivity adjusted for glucose effectiveness

The New Clinical Trials Regulation EU No 536/2014 - Amendments to the German Drug Law

New Biosimilar Insulin Study Published

Oral insulins still under development

Profil Online Seminar Series on Diabetes and Obesity

"Profil World" - The clinical diabetes research newsletter's January 2017 edition

Improved Algorithm for Automated Glucose Clamps

Dr. Tim Heise about Profil's 2016 Science Report

Liver first ? Part III: Medical Needs

Liver first ? Part II: NASH and NAFLD

Modifying insulin kinetics - requirements and limitations (Part 2)

Glucagon - the rising star in diabetes research (Part 2)

"Profil World" - Novel clamp method, upcoming online seminar with JJ Meier, history of Glucagon research

Profil scientists publish new clamp method to evaluate glucose measurement performance

Glucagon - the rising star in diabetes research (Part 1)

TECOS study: No CVD risk or heart failure with sitagliptin in high-risk diabetes patients

Medications for type 2 diabetes: a short historical perspective

Federal State Minister visited Profil

Business Trends in Diabetes Care

100% would recommend running a clinical trial at Profil

Modifying insulin kinetics - clinical requirements and limitations (Part 1)

Clinical Data Management - would you like to become a specialist or an all-rounder?

"Profil World" - The clinical diabetes research newsletter's July edition

Liver first? The liver in diabetes and cardiovascular disease (Part I)

New review of hyperinsulinemic euglycemic glucose clamp technique

Press Release - Profil takes legal action to ensure continued support of its valued customers in the United States

Addressing postprandial glucose excursion – What is the evidence?

Walking the GIR-smoothing tightrope – data refinement versus data impairment

Profil congratulates Senseonics on CE Mark for 90-day implantable CGM sensor

The New Clinical Trials Regulation EU No 536/2014 - Update (02/2017)

What does a CRA do at Profil?

Ever considered becoming a research physician at a CRO?

Choosing markers of glycemic control during clinical trial design

Profil World #4: Diabetes News from Germany

Understanding Insulin Resistance   (Part 2)

Understanding Insulin Resistance   (Part 1)

Impressions of Roche Diabetes #social media dialogue 2016

Profil partners with preclinical CRO Physiogenex

What is a Recruitment Coordinator?

Profil further strengthens scientific focus

Free Profil Online Seminar on the development of the artificial pancreas

"Profil World" - The clinical diabetes research newsletter

Profil Science Report 2015 is now available

Profil experts publish book on clinical advances in diabetes mellitus

Profil is happy to announce a new company brochure

What is a data manager?

Update on the new clinical trial regulations

Clinical development of insulin biosimilars

What did you say a study nurse does?

Open innovation: what’s going on in the healthcare sector?

Open innovation: what is it and how does it work?

Profil Germany launches new website

Free Online Seminar on biosimilar insulin development